MR-guided radiation for pancreas tumors in MEN1 patients
Part of Cancer, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests a precise, MRI-guided radiation plan for certain small pancreas neuroendocrine tumors in people with MEN1. It may help control tumor growth when surgery is needed or when remaining small tumor spots are left after prior surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have MEN1 (Multiple Endocrine Neoplasia type 1).
- You have a pancreatic neuroendocrine tumor (pNET) lesion between 2 and 3 cm, OR a smaller lesion (1.0 to 2.0 cm) that has shown certain growth patterns on scans.
- Your tumor board says the tumor needs surgery, or you have a 1.0 to 2.0 cm spot left after a previous resection of a larger tumor.
- Your pNET is not considered suspicious for cancer spread or aggressive behavior by the tumor board.
- You can safely have MRI scans (no unsafe metal/electronic implants and not unable to tolerate MRI).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of MRI-guided radiation therapy for people with locally advanced pancreatic cancer that can't be removed by surgery. If you have already had 2 months of chemotherapy, or chose not to, this treatment might help control the tumor.
This study tests a type of high-precision radiation guided by MRI pictures to treat certain cancers. It may help doctors deliver radiation more accurately while avoiding nearby healthy tissue, but you must be able to safely complete an MRI scan and meet tumor-size and health requirements.
This trial tests a higher dose of radiation guided by MRI for people with pancreatic cancer that cannot be removed by surgery or is borderline removable. It aims to improve treatment effectiveness after initial chemotherapy.
This trial studies using MRI scans to guide radiation therapy for locally advanced pancreas cancer or liver cancer. It may help make radiation planning more precise, either to control the cancer or to ease symptoms.
This early-phase study tests a new way to deliver focused radiation using MRI guidance and tiny particles, aiming to treat certain central lung tumors or locally advanced pancreatic cancer. It’s designed to see how safe it is and how well it can control these tumors.
This trial tests a procedure that uses an endoscope and ultrasound to heat (radiofrequency ablate) pancreatic neuroendocrine tumors. It may help shrink tumors while aiming to be a less invasive option.
Hear when a new Neuroendocrine Tumor of Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.